Cite
MLA Citation
Karlaina JL Osmon et al.. “MG-110 Intravenous neonatal gene therapy corrects GM2 gangliosidoses in sandhoff mice for 'long-term', by using an aav expressing a new hexosaminidase variant.” Journal of medical genetics, vol. 52, n.d., p. A4. http://access.bl.uk/ark:/81055/vdc_100135156013.0x00003d